FCN1 and acute myeloid leukemia: Low ficolin-1 levels (< 620 ng/ml) were therefore very common among patients with AML (71.8%) in comparison with healthy controls (10.2%) [p < 0.00001, OR = 23.4, 95% CI (13.64–40.2)].